Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Brooks Life Science Systems Introduced at the Inaugural SLAS2012 Conference

Published: Tuesday, February 07, 2012
Last Updated: Tuesday, February 07, 2012
Bookmark and Share
Company has an installed global base of more than 180 systems, including installations at the world’s top 20 pharmaceutical and biotechnology companies.

Dr. Steve Schwartz, President and CEO of Brooks Automation, said, “Brooks entered into the Life Sciences market in 2011 and now, with the acquisitions of industry specialists RTS Life Science, REMP®, and Nexus Biosystems, we have chosen the prestigious SLAS Conference to rollout our full offering to the Life Science industry. In Brooks Life Science Systems we combine the expertise and experience of these three leading sample management companies, alongside the extensive R&D capabilities and global service reach of Brooks Automation.”
   
“This is an exciting time as we continue to build on our long term commitment to supporting life science research,” commented Clint Haris, Senior Vice President, General Manager, Brooks Life Science Systems. “As pioneers in automation, we are wholly committed to focusing our R&D activities on pushing the boundaries of automated sample management and storage. Our mission is to continuously provide innovative solutions that improve sample integrity and data security during automated sample storage and management, as well as advancing the operational performance and efficiencies of our systems.”

At the conference, Booth #918, Brooks Life Science Systems will be showcasing the latest solutions in automated storage and its portfolio of products designed to meet the most demanding needs in sample management including its most recent product acquisitions, Celigo® and Plate Auditor™. Celigo is a high throughput, microplate-based, imaging cell cytometer and analysis system. Celigo provides high productivity automated solutions for the analysis, handling and testing of biological and compound samples prior to and following their storage in automated sample management systems.  The Brooks Plate Auditor will help Compound Sample Managers analyze the quality of their compounds following storage and prior to the sample’s entry into the high throughput screening phase of the drug discovery process.  Brooks will be hosting a tutorial: “Automated Biorepository Sample Workflow”, at the SLAS Conference on Tuesday, February 7th, 8:00 a.m. – 8:50 a.m., Room 8 on the upper level of the San Diego Convention Center.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Crucial for Stem Cell Survival Protein Identified Using Editing Tool CRISPR
A team of University of Wisconsin-Madison engineers has identified a protein that is integral to the survival and self-renewal processes of human pluripotent stem cells (hPSC).
A Gene-Sequence Swap Using CRISPR to Cure Haemophilia
For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Zebrafish Reveal Drugs that may Improve Bone Marrow Transplant
Compounds boost stem cell engraftment; could allow more matches for patients with cancer and blood diseases.
New Material Forges the Way for 'Stem Cell Factories'
Researchers have discovered the first fully synthetic substrate with potential to grow billions of stem cells. The researchcould forge the way for the creation of 'stem cell factories' - the mass production of human embryonic (pluripotent) stem cells.
Liver Regrown from Stem Cells
Scientists have repaired a damaged liver in a mouse by transplanting stem cells grown in the laboratory.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
'Google Maps' for the Body
Scientists have revealed research that uses previously top-secret technology to zoom through the human body down to the level of a single cell that could be a game-changer for medicine.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!